What is the role of antimicrobial resistance in the new epidemic of Clostridium difficile?

被引:18
作者
Coia, John E. [1 ]
机构
[1] Stobhill Hosp, Scottish Salmonella Shigella & Clostridium Diffic, Glasgow G21 3UW, Lanark, Scotland
关键词
Clostridium difficile; Antimicrobial drug resistance; PCR ribotype 027; Epidemic; TOXIN PRODUCTION; CECAL CONTENTS; DISEASE; FLUOROQUINOLONES; SUSCEPTIBILITY; METRONIDAZOLE; EMERGENCE; DIARRHEA; GROWTH; STRAIN;
D O I
10.1016/S0924-8579(09)70009-3
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The epidemiology of Clostridium difficile infection (CDI) has changed in recent years, with the occurrence of large outbreaks of infection associated with the emergence of 'hypervirulent' strains, particularly PCR ribotype 027. There has been much speculation as to the nature of the factors responsible for driving the new epidemic of CDI, and various hypotheses have been proposed. These include increases in the size of the population at risk of CDI and/or their susceptibility to infection, increased exposure to the organism, and changes in the virulence/transmissibility of the pathogen. Resistance to a range of antimicrobial agents, including the. uoroquinolones, is a common feature of these newly emerged strains. This article considers the part antimicrobial resistance may play as a driver for the observed changes in the epidemiology of CDI and presents a model that would support such a role. However, the paucity of definitive evidence for a causal role and the complexity of the epidemiology of CDI are acknowledged. It may be more accurate to view antimicrobial resistance as one of a range of factors which interact to alter the parameters of the 'CDI equation', and thereby determine the size of the CDI problem associated with any given emerging subtype of C. difficile. (C) 2009 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:S9 / S12
页数:4
相关论文
共 21 条
[1]   Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic Clostridium difficile strains in the Cecal contents of mice [J].
Adams, Daniel A. ;
Riggs, Michelle M. ;
Donskey, Curtis J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (08) :2674-2678
[2]   Emergence of reduced susceptibility to metronidazole in Clostridium difficile [J].
Baines, Simon D. ;
O'Connor, Rachael ;
Freeman, Jane ;
Fawley, Warren N. ;
Harmanus, Celine ;
Mastrantonio, Paola ;
Kuijper, Ed J. ;
Wilcox, Mark H. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) :1046-1052
[3]  
Cunningham R, 2008, J HOSP INFECT, V70, P1, DOI 10.1016/j.jhin.2008.04.023
[4]   Antibiotic resistant Staphylococcus aureus:: a paradigm of adaptive power [J].
De Lencastre, Herminia ;
Oliveira, Duarte ;
Tomasz, Alexander .
CURRENT OPINION IN MICROBIOLOGY, 2007, 10 (05) :428-435
[5]  
*DIFF WORK GROUP, 2007, ANN REP SURV CLOSTR
[6]   Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea:: This is an antimicrobial resistance problem [J].
Gerding, DN .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (05) :646-648
[7]   Immunosenescence: deficits in adaptive immunity in the elderly [J].
Hakim, F. T. ;
Gress, R. E. .
TISSUE ANTIGENS, 2007, 70 (03) :179-189
[8]   A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C-difficile-associated disease in Quebec [J].
Hubert, Bruno ;
Loo, Vivian G. ;
Bourgault, Anne-Marie ;
Poirier, Louise ;
Dascal, Andre ;
Fortin, Elise ;
Dionne, Marc ;
Lorange, Manon .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (02) :238-244
[9]   Toxinotype V Clostridium difficile in humans and food animals [J].
Jhung, Michael A. ;
Thompson, Angela D. ;
Killgore, George E. ;
Zukowski, Walter E. ;
Songer, Glenn ;
Warny, Michael ;
Johnson, Stuart ;
Gerding, Dale N. ;
McDonald, L. Clifford ;
Limbago, Brandi M. .
EMERGING INFECTIOUS DISEASES, 2008, 14 (07) :1039-1045
[10]   Emergence of Clostridium difficile-associated disease in North America and Europe [J].
Kuijper, E. J. ;
Coignard, B. ;
Tull, P. .
CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 :2-18